相关实验视频
Updated: Jan 9, 2026

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
967
探索无处不在的监管网络:为类风湿性关节炎治疗开辟新的视角
Fanfan Wang1,2, Jian Liu1,2, Jianting Wen2
1The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.
Annals of medicine
|December 10, 2025
概括
类风湿性关节炎 (RA) 涉及慢性炎症. 本综述探讨了蛋白质修饰的ubiquitination是如何驱动RA病变的,并为这种自身免疫性疾病提供了潜在的新治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 类风湿性关节炎 (RA) 是一种自身免疫性疾病,导致慢性系统性炎症,关节损伤和关节外问题.
- 驱动RA病变的精确机制尚未完全理解.
- 作为一个关键的翻译后修饰,乌比基因化对于免疫调节和炎症反应至关重要.
研究的目的:
- 为了提供一个全面的概述在类风湿性关节炎的ubiquitination的作用.
- 阐明无处不在对RA发展的机制性贡献.
- 评估针对RA中无化途径的治疗潜力.
主要方法:
- 关于与RA相关的无处不在化研究近期进展的文献综述.
- 对在RA病理生理学中无处不在的作用的机制学研究的分析.
- 评估关于无处不在向治疗的临床前和临床数据.
主要成果:
- 乌比基提尼在调节关联于RA的炎症信号通路方面发挥着至关重要的作用.
- 特定的无化过程的调节失调有助于RA的突性炎症和关节破坏.
- 在临床前模型中,准无处不在的途径对减少与RA相关的炎症和损伤有很大的希望.
结论:
- 乌比基因化是类风湿性关节炎发病的一个重要因素.
- 准无处不在的途径代表了RA的有前途的治疗策略.
- 对无处不在机制的进一步研究可能会导致新的RA治疗方法.
相关概念视频
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Receptor Downregulation in MVBs
2.7K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.7K
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
Regulation of Expression at Multiple Steps
1.3K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.3K
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K

